Molecular and clinicopathologic features of gliomas harboring NTRK fusions
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Molecular and clinicopathologic features of gliomas harboring NTRK fusions
Authors
Keywords
-
Journal
Acta Neuropathologica Communications
Volume 8, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-07-14
DOI
10.1186/s40478-020-00980-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Infant high grade gliomas comprise multiple subgroups characterized by novel targetable gene fusions and favorable outcomes
- (2020) Matthew Clarke et al. Cancer Discovery
- Larotrectinib in adult patients with solid tumours: a multicentre, open-label, phase I dose-escalation study
- (2019) D S Hong et al. ANNALS OF ONCOLOGY
- High-grade glioneuronal tumor with an ARHGEF2–NTRK1 fusion gene
- (2019) Kazuhiko Kurozumi et al. Brain Tumor Pathology
- Detection of Tumor NTRK Gene Fusions to Identify Patients Who May Benefit from TRK Inhibitor Therapy
- (2019) Susan J. Hsiao et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Detection of NTRK Fusions: Merits and Limitations of Current Diagnostic Platforms
- (2019) James P. Solomon et al. CANCER RESEARCH
- Desmoplastic Infantile Ganglioglioma: A MAPK Pathway-Driven and Microglia/Macrophage-Rich Neuroepithelial Tumor
- (2019) Melissa M Blessing et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Characterization of molecular signatures of supratentorial ependymomas
- (2019) Matthew Torre et al. MODERN PATHOLOGY
- NTRK fusion detection across multiple assays and 33,997 cases: diagnostic implications and pitfalls
- (2019) James P. Solomon et al. MODERN PATHOLOGY
- Larotrectinib imaging response in low‐grade glioma
- (2019) Andrew W. Walter et al. PEDIATRIC BLOOD & CANCER
- TRK inhibitors in TRK fusion-positive cancers
- (2019) A Drilon ANNALS OF ONCOLOGY
- Tropomyosin receptor kinase (TRK) biology and the role of NTRK gene fusions in cancer
- (2019) A Amatu et al. ANNALS OF ONCOLOGY
- Deep multiomics profiling of brain tumors identifies signaling networks downstream of cancer driver genes
- (2019) Hong Wang et al. Nature Communications
- Alterations in ALK/ROS1/NTRK/MET drive a group of infantile hemispheric gliomas
- (2019) Ana S. Guerreiro Stucklin et al. Nature Communications
- TRK Fusions are Enriched in Cancers with Uncommon Histologies and the Absence of Canonical Driver Mutations
- (2019) Ezra Y Rosen et al. CLINICAL CANCER RESEARCH
- Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1–2 trials
- (2019) Robert C Doebele et al. LANCET ONCOLOGY
- Practical implementation of DNA methylation and copy-number-based CNS tumor diagnostics: the Heidelberg experience
- (2018) David Capper et al. ACTA NEUROPATHOLOGICA
- Molecularly defined diffuse leptomeningeal glioneuronal tumor (DLGNT) comprises two subgroups with distinct clinical and genetic features
- (2018) Maximilian Y. Deng et al. ACTA NEUROPATHOLOGICA
- Targetable Gene Fusions Associate With the IDH Wild-Type Astrocytic Lineage in Adult Gliomas
- (2018) Sherise D Ferguson et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: phase 1 results from a multicentre, open-label, phase 1/2 study
- (2018) Theodore W Laetsch et al. LANCET ONCOLOGY
- DNA methylation-based classification of central nervous system tumours
- (2018) David Capper et al. NATURE
- Novel TLE4-NTRK2 fusion in a ganglioglioma identified by array-CGH and confirmed by NGS: Potential for a gene targeted therapy
- (2018) Nitya Prabhakaran et al. NEUROPATHOLOGY
- CDKN2A/B Loss Is Associated with Anaplastic Transformation in a Case of NTRK2 Fusion-positive Pilocytic Astrocytoma
- (2018) G. Y. López et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- Efficacy of Larotrectinib in TRK Fusion–Positive Cancers in Adults and Children
- (2018) Alexander Drilon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Brief Report: Potent clinical and radiological response to larotrectinib in TRK fusion-driven high-grade glioma
- (2018) David S. Ziegler et al. BRITISH JOURNAL OF CANCER
- Molecular characterization of cancers with NTRK gene fusions
- (2018) Zoran Gatalica et al. MODERN PATHOLOGY
- Expanding the spectrum of pediatric NTRK -rearranged fibroblastic tumors to the central nervous system: A case report with RBPMS-NTRK3 fusion
- (2018) Matthew Torre et al. NEUROPATHOLOGY
- NTRK fusion-positive cancers and TRK inhibitor therapy
- (2018) Emiliano Cocco et al. Nature Reviews Clinical Oncology
- SETD2 mutations in primary central nervous system tumors
- (2018) Angela N. Viaene et al. Acta Neuropathologica Communications
- Targeting TRK family proteins in cancer
- (2017) Yekaterina B. Khotskaya et al. PHARMACOLOGY & THERAPEUTICS
- Somatic chromosomal engineering identifies BCAN-NTRK1 as a potent glioma driver and therapeutic target
- (2017) Peter J. Cook et al. Nature Communications
- Safety and Antitumor Activity of the Multitargeted Pan-TRK, ROS1, and ALK Inhibitor Entrectinib: Combined Results from Two Phase I Trials (ALKA-372-001 and STARTRK-1)
- (2017) Alexander Drilon et al. Cancer Discovery
- Genetic alterations in uncommon low-grade neuroepithelial tumors: BRAF, FGFR1, and MYB mutations occur at high frequency and align with morphology
- (2016) Ibrahim Qaddoumi et al. ACTA NEUROPATHOLOGICA
- New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs
- (2016) Dominik Sturm et al. CELL
- Entrectinib, a Pan-TRK, ROS1, and ALK Inhibitor with Activity in Multiple Molecularly Defined Cancer Indications
- (2016) E. Ardini et al. MOLECULAR CANCER THERAPEUTICS
- Tyrosine receptor kinase B is a drug target in astrocytomas
- (2016) Jing Ni et al. NEURO-ONCOLOGY
- Durable Clinical Response to Entrectinib in NTRK1-Rearranged Non-Small Cell Lung Cancer
- (2015) Anna F. Farago et al. Journal of Thoracic Oncology
- The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma
- (2014) Gang Wu et al. NATURE GENETICS
- Anchored multiplex PCR for targeted next-generation sequencing
- (2014) Zongli Zheng et al. NATURE MEDICINE
- The landscape and therapeutic relevance of cancer-associated transcript fusions
- (2014) K Yoshihara et al. ONCOGENE
- The landscape of kinase fusions in cancer
- (2014) Nicolas Stransky et al. Nature Communications
- TRKing Down an Old Oncogene in a New Era of Targeted Therapy
- (2014) Aria Vaishnavi et al. Cancer Discovery
- Exploration of the gene fusion landscape of glioblastoma using transcriptome sequencing and copy number data
- (2013) Nameeta Shah et al. BMC GENOMICS
- The integrated landscape of driver genomic alterations in glioblastoma
- (2013) Veronique Frattini et al. NATURE GENETICS
- Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma
- (2013) David T W Jones et al. NATURE GENETICS
- Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas
- (2013) NATURE GENETICS
- clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters
- (2012) Guangchuang Yu et al. OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY
- Human TrkB gene: novel alternative transcripts, protein isoforms and expression pattern in the prefrontal cerebral cortex during postnatal development
- (2010) Kristi Luberg et al. JOURNAL OF NEUROCHEMISTRY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started